CYTOFLUOROMETRIC AND FUNCTIONAL-ANALYSIS OF C-KIT RECEPTOR IN ACUTE-LEUKEMIA

被引：17

作者：

LAURIA, F

BAGNARA, GP

RONDELLI, D

RASPADORI, D

STRIPPOLI, P

BONSI, L

VENTURA, MA

MONTANARO, LL

BUBOLA, G

TURA, S

BROUDY, VC

机构：

[1] Istituto di Scienze Mediche, Università di Milano

[2] Istituto di Istologia ed Embriologia Generale, Università di Bologna

[3] Department of Medicine, Division of Hematology, University of Washington, Seattle, WA

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 18卷 / 5-6期

关键词：

C-KIT RECEPTOR; ACUTE LEUKEMIA; STEM CELL FACTOR;

D O I：

10.3109/10428199509059644

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The SR-1 monoclonal antibody (MoAb) recognizes an epitope of the c-kit receptor (KR), present on normal hemopoietic CD34+ stem cells as well as on blasts from patients with acute leukemia. Cytometric analysis by indirect immunofluorescence with the SR-1 MoAb was performed in 98 patients with acute myeloblastic leukemia (AML) and in 37 patients with acute lymphoblastic leukemia (ALL) in order to detect the presence of the KR and to examine its prognostic significance. Sixty-nine of 98 (70%) AML patients were SR-1 positive independently of the FAB subtype, although a higher incidence of SR-1 positive cases was observed in M4 and M5 AML and in those cases that also coexpressed lymphoid antigens. Fourteen AML samples were studied by Northern blot analysis and the KR mRNA was detected in the majority of SR-1 positive cases and also in 2 of 3 SR-1 negative samples. Furthermore, ''in vitro'' cultures from 15 cases showed that recombinant human Stem cell factor (rhSCF) induced an increased proliferative activity in most tested cases (11/15); this was further enhanced when rhSCF was combined with rhIL-3 + rhGM-CSF (p = 0.007) and with the GM-CSF/IL-3 fusion protein PIXY321 (p = 0.003). Thirty-seven ALL cases were also studied and all but one were SR-1 negative. Interestingly, the only SR-1 positive case also coexpressed myeloid antigens and showed an ''in vitro'' response when stimulated with rhSCF. Finally, the complete remission (CR) rate, survival and event-free survival were evaluated in 75 AML patients who received standard and identical chemotherapy; unlike previous studies which utilized a different anti-KR MoAb (YB5.B8) and which showed a poor prognosis for KR positive patients, we were unable to document any significant difference in CR rate, survival and event-free survival.

引用

页码：451 / 455

页数：5

共 26 条

[1]

Yarden Y., Kuang W.J., Yang-Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U., Ulrich A., Human proto-oncogene c-kit: a new cell surtace receptor ty-rosine kinase for an unidentified ligand, EMBO J., 6, pp. 3341-3351, (1987)

[2]

Zsebo K.M., Williams D.A., Geissler E.N., Broudy V.C., Martin F.H., Atkins H.L., Hsu R., Birkett N.C., Okino K.H., Murdoch D.C., Jacobsen F.W., Langley K.E., Smith K.A., Takeishi T., Cattanach B.M., Galli S.J., Suggs S.V., Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor, Cell, 63, pp. 213-224, (1990)

[3]

Williams D.E., Eisenman J., Baird A., Rauch C., Van-Ness K., March C.J., Park L.S., Martin U., Mochizuki D.Y., Boswell H.C., Burgess G.S., Cosman D., Lyman S.D., Identification of a l igand for the c-kit proto-oncogene, Cell, 63, pp. 167-174, (1990)

[4]

Blechman J.M., Lev S., Givol D., Yarden Y., Structure-function analyses of the Kit Receptor for the Steel Factor, Stem Cells, 11, pp. 12-21, (1993)

[5]

Papayanopoulou T., Bice M., Broudy V.C., Zsebo K.M., Isolation of c-kit receptor expressing cells from bone marrow, peripheral blood, and fet al liver: functional properties and composite antigenic profile, Blood, 78, pp. 1403-1412, (1991)

[6]

Andrews R.G., Knitter G.H., Bartelmez S.H., Langley K.E., Ferrar D., Hendren R.W., Appelbaum F.R., Benlstein I.D., Zsebo K.M., Recombinant human stem cell factor. a c-kit ligand, stimulates hematopoiesis in primates, Blood, 78, pp. 1975-1980, (1991)

[7]

Brandt J., Briddel R.A., Srour E.F., Leemhuis T.B., Hoffman R., Role of c-kit ligand in the expansion of human hematopoietic progenitors cells, Blood, 79, pp. 634-641, (1992)

[8]

Brizzi M.F., Pavan M., Zini M.G., Avanzi G.C., Pegoraro L., Regulation of c-kit expression in human myeloid cells, Slein Cells, 11, pp. 42-48, (1903)

[9]

Berreti A., Lev S., Bassous L., Chemia M., Leitner O., Givol D., Yarden Y., Expression of the stem cell factor, c-kit, in normal and leukemic patients: enhanced expression post-chemotherapy and overexpression in an aggressive stem cell leukemia, Blood, 78, (1991)

[10]

Ratajczak M.Z., Luger S.M., De Riel K., Abrahni J., Calabretta H., Gewirtz A.M., Role of the kit protooncogene in normal and malignant human hematopoiesis, Proc. Natl. Acad. Sci. USA, 89, pp. 1710-1714, (1992)

← 1 2 3 →